Skye Bioscience, Inc. Financing Cash Flow
Skye Bioscience, Inc. (SKYE) reported Financing Cash Flow of -$172.54 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$101.01K, a 656.31% decline year-over-year.
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$71.53K.
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $11.41K, a 103.15% increase year-over-year.
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $29.57K, a 99.96% decline from fiscal 2024.
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $83.56M, a 408.18% increase from fiscal 2023.
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $16.44M.
- Skye Bioscience, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$208.79K, a 101.60% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$101.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$172.54K 10-Q · filed 2026-08-14 | -$161.13K derived: sum of 3 quarters · filed 2026-08-14 | -$161.13K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$71.53K 10-Q · filed 2026-05-11 | -$60.11K derived: sum of 2 quarters · filed 2026-05-11 | -$60.11K derived: sum of 3 quarters · filed 2026-05-11 | -$41.95K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $11.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $11.41K derived: sum of 2 quarters · filed 2026-03-10 | $29.57K derived: sum of 3 quarters · filed 2026-08-14 | $29.57K 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $18.16K derived: sum of 2 quarters · filed 2026-08-14 | $18.16K 10-Q · filed 2025-11-10 | $23.78K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $18.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $18.16K 10-Q · filed 2026-08-14 | $23.78K derived: sum of 3 quarters · filed 2026-08-14 | $23.78K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $5.62K derived: sum of 2 quarters · filed 2026-05-11 | $5.62K derived: sum of 3 quarters · filed 2026-05-11 | -$2.09M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $5.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $5.62K derived: sum of 2 quarters · filed 2026-03-10 | -$2.09M derived: sum of 3 quarters · filed 2026-03-10 | $83.56M 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.10M derived: sum of 2 quarters · filed 2025-11-10 | $83.56M 10-Q · filed 2025-11-10 | $83.53M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $83.56M 10-Q · filed 2025-08-07 | $83.53M derived: sum of 3 quarters · filed 2025-08-07 | $100.17M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $85.65M 10-Q · filed 2025-05-08 | $85.63M derived: sum of 2 quarters · filed 2025-05-08 | $102.26M derived: sum of 3 quarters · filed 2025-05-08 | $102.14M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$22.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $16.61M derived: sum of 2 quarters · filed 2025-03-20 | $16.49M derived: sum of 3 quarters · filed 2025-03-20 | $16.44M 10-K · filed 2025-03-20 |
| 2023-09-30 | $16.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $16.51M derived: sum of 2 quarters · filed 2024-11-07 | $16.47M 10-Q · filed 2024-11-07 | $16.50M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$123.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$168.72K 10-Q · filed 2024-08-09 | -$134.56K derived: sum of 3 quarters · filed 2024-08-09 | -$226.41K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$45.31K 10-Q · filed 2024-05-10 | -$11.15K derived: sum of 2 quarters · filed 2024-05-10 | -$102.99K derived: sum of 3 quarters · filed 2024-05-10 | -$194.84K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $34.16K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$57.69K derived: sum of 2 quarters · filed 2024-03-22 | -$149.53K derived: sum of 3 quarters · filed 2024-03-22 | -$208.79K 10-K · filed 2024-03-22 |
| 2022-09-30 | -$91.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$183.69K derived: sum of 2 quarters · filed 2023-11-14 | -$242.96K 10-Q · filed 2023-11-14 | -$326.68K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$91.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$151.11K 10-Q · filed 2023-08-07 | -$234.83K derived: sum of 3 quarters · filed 2023-08-07 | $7.18M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$59.26K 10-Q · filed 2023-05-12 | -$142.99K derived: sum of 2 quarters · filed 2023-05-12 | $7.27M derived: sum of 3 quarters · filed 2023-05-12 | $8.98M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$83.72K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $7.33M derived: sum of 2 quarters · filed 2023-03-31 | $9.04M derived: sum of 3 quarters · filed 2023-03-31 | $13.08M 10-K · filed 2023-03-31 |
| 2021-09-30 | $7.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $9.12M derived: sum of 2 quarters · filed 2022-11-14 | $13.16M 10-Q · filed 2022-11-14 | $13.20M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $5.75M 10-Q · filed 2022-08-15 | $5.78M derived: sum of 3 quarters · filed 2022-08-15 | $11.88M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $4.04M 10-Q · filed 2022-05-06 | $4.08M derived: sum of 2 quarters · filed 2022-05-06 | $10.18M derived: sum of 3 quarters · filed 2022-05-06 | $10.74M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $6.13M derived: sum of 2 quarters · filed 2022-03-28 | $6.70M derived: sum of 3 quarters · filed 2022-03-28 | $6.70M 10-K · filed 2022-03-28 |
| 2020-09-30 | $6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $6.66M derived: sum of 2 quarters · filed 2021-11-10 | $6.66M 10-Q · filed 2021-11-10 | $8.68M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $566.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $566.70K 10-Q · filed 2021-08-06 | $2.58M derived: sum of 3 quarters · filed 2021-08-06 | $2.58M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $2.01M derived: sum of 2 quarters · filed 2021-05-07 | $2.01M derived: sum of 3 quarters · filed 2021-05-07 | $2.01M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $2.01M derived: sum of 2 quarters · filed 2021-03-02 | $2.01M derived: sum of 3 quarters · filed 2021-03-02 | $6.00M 10-K · filed 2021-03-02 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $3.99M 10-Q · filed 2020-11-06 | $5.80M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $3.99M 10-Q · filed 2020-08-13 | $5.80M derived: sum of 3 quarters · filed 2020-08-13 | $5.80M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $3.99M 10-Q · filed 2020-05-08 | $5.80M derived: sum of 2 quarters · filed 2020-05-08 | $5.80M derived: sum of 3 quarters · filed 2020-05-08 | $5.79M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $1.81M derived: sum of 2 quarters · filed 2020-03-23 | $1.80M derived: sum of 3 quarters · filed 2020-03-23 | $5.54M 10-K · filed 2020-03-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$7.78K derived: sum of 2 quarters · filed 2019-11-14 | $3.73M 10-Q · filed 2019-11-14 | $6.11M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$7.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $3.73M 10-Q · filed 2019-08-09 | $6.11M derived: sum of 3 quarters · filed 2019-08-09 | $6.11M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $3.74M 10-Q · filed 2019-05-10 | $6.12M derived: sum of 2 quarters · filed 2019-05-10 | $6.12M derived: sum of 3 quarters · filed 2019-05-10 | |
| 2017-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.38M derived: sum of 2 quarters · filed 2019-03-14 | $3.51M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.13M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $1.13M 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |